SAS code for the estimation and between-group comparison of cumulative incidence functions in competing risks survival analysis

Author： Bond Simon

Publisher： Maney Publishing

ISSN： 1757-093X

Source： Pharmaceutical Programming, Vol.4, Iss.1-2, 2011-12, pp. : 1-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Competing Risks Prescription Refill Model of Compliance and Persistence

By Barron T. Ian Bennett Kathleen Feely John

Value in Health, Vol. 13, Iss. 6, 2010-09 ,pp. : 796-804

Blackwell Publishing

Access to resources Recommend Favorite

Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis

By Peterson Kim McDonagh Marian Fu Rongwei

Psychopharmacology, Vol. 197, Iss. 1, 2008-03 ,pp. : 1-11

Springer Publishing Company

Access to resources Recommend Favorite

Drug Disposition Analysis: A Comparison Between Budesonide and Fluticasone

By Källén Anders Thorsson Lars

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 30, Iss. 4, 2003-08 ,pp. : 239-256

Springer Publishing Company

Access to resources Recommend Favorite

Using Dose Addition to Estimate Cumulative Risks from Exposures to Multiple Chemicals

By Chen J.J. Chen Y-J. Rice G. Teuschler L.K. Hamernik K. Protzel A. Kodell R.L.

Regulatory Toxicology and Pharmacology, Vol. 34, Iss. 1, 2001-08 ,pp. : 35-41

Academic Press

Access to resources Recommend Favorite

Comparison between the effects of receptor ligand JO 1784 and neuropeptide Y on immune functions

By Song C. Leonard B.E.

European Journal of Pharmacology, Vol. 345, Iss. 1, 1998-03 ,pp. : 79-87

Elsevier

Access to resources Recommend Favorite